S. Shankar

发表

High throughput LC-MS method to investigate postprandial lipemia: Considerations for future precision nutrition research.

Michael E. Lassman, Jennifer E. Vena, E. Parks, 2021, American journal of physiology. Endocrinology and metabolism.

High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins.

J. H. Rudd, Z. Fayad, M. Farkouh, 2013, Journal of the American College of Cardiology.

Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series

R. Bergman, C. Cobelli, C. Dalla Man, 2016, Diabetes Care.

Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes

C. Beals, D. Kelley, R. Shankar, 2018, Diabetes.

Linearity of β-cell response across the metabolic spectrum and to pharmacology: insights from a graded glucose infusion-based investigation series.

C. Beals, D. Kelley, R. Shankar, 2016, American journal of physiology. Endocrinology and metabolism.

Acute Insulin Response and β-Cell Compensation in Normal Subjects Treated With Olanzapine or Risperidone for 2 Weeks

T. Hardy, N. Porksen, S. Shankar, 2007, Diabetes Care.

Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo.

A. Breier, S. Shankar, C. Beasley, 2002, The Journal of clinical endocrinology and metabolism.

Weight loss and vascular function: the good and the unknown.

S. Shankar, H. Steinberg, 2008, Hypertension.

Insulin secretory effect of sitagliptin: assessment with a hyperglycemic clamp combined with a meal challenge.

C. Beals, D. Kelley, R. Shankar, 2018, American journal of physiology. Endocrinology and metabolism.

Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.

C. Cobelli, M. Staten, R. Robertson, 2018, Metabolic syndrome and related disorders.

Outpatient versus inpatient mixed meal tolerance and arginine stimulation testing yields comparable measures of variability for assessment of beta cell function

C. Cobelli, M. Staten, R. Robertson, 2018, Contemporary clinical trials communications.

Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity.

R. Considine, S. Shankar, K. March, 2006, American journal of physiology. Endocrinology and metabolism.

High-Dose Atorvastatin Reduces Periodontal Inflammation

Z. Fayad, M. Farkouh, T. E. Dyke, 2013 .

Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist

N. Chalasani, T. Hardy, S. Pillai, 2018, Hepatology communications.

Loop diuretics: from the Na-K-2Cl transporter to clinical use.

S. Shankar, D. Brater, D. Brater, 2003, American journal of physiology. Renal physiology.

Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha.

C. Lelliott, A. Vidal-Puig, R. Considine, 2005, Obesity research.

Metabolic improvements following Roux-en-Y surgery assessed by solid meal test in subjects with short duration type 2 diabetes

C. Beals, R. Considine, D. Kelley, 2017, BMC Obesity.

Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes

N. Chalasani, T. Hardy, S. Pillai, 2017, Diabetes, obesity & metabolism.

l‐Carnitine May Attenuate Free Fatty Acid‐Induced Endothelial Dysfunction

S. Shankar, J. Walsh, H. Steinberg, 2004, Annals of the New York Academy of Sciences.

Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease

K. Cusi, S. Shankar, D. Barb, 2021, Obesity.

Acute Insulin Response and β-Cell Compensation in Normal Subjects Treated With Olanzapine or Risperidone for 2 Weeks

T. Hardy, S. Shankar, H. Steinberg, 2007, Diabetes Care.

An ultrasensitive method for the quantitation of active and inactive GLP-1 in human plasma via immunoaffinity LC-MS/MS.

Michael E. Lassman, N. Yates, O. Laterza, 2014, Bioanalysis.

Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis: the FNIH NIMBLE project

Kathryn J Fowler, A. Samir, C. Sirlin, 2022, Nature Medicine.

High nitric oxide production in autistic disorder: a possible role for interferon-γ

C. McDougle, D. Posey, S. Shankar, 2004, Biological Psychiatry.

Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post‐hoc analysis of the AWARD‐2, ‐4 and ‐5 Trials

Sherry A. Martin, A. Peters, S. Shankar, 2018, Diabetes, obesity & metabolism.

FFAs: Do they play a role in vascular disease in the insulin resistance syndrome?

S. Shankar, H. Steinberg, 2005, Current diabetes reports.

Arginine is preferred to glucagon for stimulation testing of β-cell function.

P. Savage, G. Weir, R. Robertson, 2014, American journal of physiology. Endocrinology and metabolism.

Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy

T. Buchanan, R. Considine, S. Shankar, 2007, Cardiovascular Toxicology.

Clinical aspects of endothelial dysfunction associated with human immunodeficiency virus infection and antiretroviral agents

S. Shankar, M. Dubé, 2007, Cardiovascular Toxicology.

Insulin Resistance and Hypertension

S. Shankar, H. Steinberg, 2013 .

An LC-MRM method for measuring intestinal triglyceride assembly using an oral stable isotope-labeled fat challenge.

Michael E. Lassman, E. Parks, O. Laterza, 2016, Bioanalysis.

Early Clinical Detection of Pharmacologic Response in Insulin Action in a Nondiabetic Insulin-Resistant Population

R. Railkar, C. Beals, D. Kelley, 2015, Current therapeutic research, clinical and experimental.

Indinavir impairs endothelial function in healthy HIV-negative men.

J. Klaunig, S. Shankar, J. Gorski, 2005, American heart journal.

Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.

Z. Fayad, C. Beals, M. Farkouh, 2013, Journal of the American College of Cardiology.

Direct comparison of radioimmunoassay and LC-MS/MS for PK assessment of insulin glargine in clinical development.

Kevin Bateman, Eric J Woolf, K. Bateman, 2014, Bioanalysis.

Insulin sensitivity is preserved despite disrupted endothelial function.

R. Considine, S. Shankar, J. Gorski, 2006, American journal of physiology. Endocrinology and metabolism.

The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis

Kathryn J Fowler, B. Neuschwander‐Tetri, J. Bolognese, 2023, Research square.

The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro

B. Hoogwerf, M. Farmen, S. Pillai, 2017, The Pharmacogenomics Journal.

Obesity and endothelial dysfunction.

S. Shankar, H. Steinberg, 2005, Seminars in vascular medicine.

Treating Postprandial Hyperglycemia Does Not Appear to Delay Progression of Early Type 2 Diabetes

J. McGill, M. S. Kirkman, A. Baron, 2006, Diabetes Care.

R. Bergman, C. Cobelli, M. Staten, 2016, Diabetes Care.

Linearity of β-cell response across the metabolic spectrum and to pharmacology: insights from a graded glucose infusion-based investigation series.

C. Beals, D. Kelley, R. Shankar, 2016, American journal of physiology. Endocrinology and metabolism.